Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Puma Biotechnology Inc | PBYI | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
4.88 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 2.13 - 7.73 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 4.88 | USD |
Puma Biotechnology Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
235.25M | 48.21M | - | 235.64M | 21.59M | 0.45 | 10.90 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Puma Biotechnology News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PBYI Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 4.92 | 5.34 | 4.72 | 5.00 | 287,135 | -0.04 | -0.81% |
1 Month | 5.42 | 6.055 | 4.72 | 5.33 | 323,625 | -0.54 | -9.96% |
3 Months | 4.87 | 7.73 | 4.14 | 5.76 | 605,923 | 0.01 | 0.21% |
6 Months | 2.21 | 7.73 | 2.16 | 5.16 | 456,282 | 2.67 | 120.81% |
1 Year | 2.72 | 7.73 | 2.13 | 4.64 | 314,469 | 2.16 | 79.41% |
3 Years | 10.16 | 11.95 | 1.60 | 4.41 | 387,003 | -5.28 | -51.97% |
5 Years | 33.65 | 33.86 | 1.60 | 8.62 | 676,721 | -28.77 | -85.50% |
Puma Biotechnology Description
Puma Biotechnology Inc is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. The company in-licenses the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357. |